Smartest Doc
Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement
Annals of Internal Medicine, 05/16/2012
Neumann I et al. – Compared with low–molecular–weight heparin (LMWH), lower doses of oral factor Xa inhibitors can achieve a small absolute risk reduction in symptomatic deep venous thrombosis without increasing bleeding.